All Soft Gels, Inc. Purchases 1200 Bottles of Liquid Creatine to Begin Production of Its All Soft Gels Kre-Alkalyn Liquid Gel Capsules

On December 15, 2016, Company Purchases 1200 Bottles of Liquid Creatine from S. T. Distributing to Kick Off Production of All Soft Gels Kre-Alkalyn Liquid Gels.

Salt Lake City, UT, March 09, 2017 --(PR.com)-- All Soft Gels, Inc., a health supplement company, announced that on December 15, 2016, it had purchased 1,200 bottled of liquid creatine from S. T. Distributing, providing the company with an important kick off for production of its All Soft Gels Kre-Alkalyn Liquid Gels. The soft gel capsule is the company’s first product and production of the capsule is the start of what CEO Gene Nelson expects will drive the company into becoming a successful long-term business venture.

“We are very excited about having made this purchase and taken a critical step toward production of the All Soft Gels Kre-Alkalyn Liquid Gels,” says Mr. Nelson, a world champion bodybuilder who has competed in and won numerous natural bodybuilding shows for more than 33 years, including most recently coming in first place at the 2014 Utah Western Fuel Championship. “This action allows us to begin production as soon as possible. It also allow us to begin taking orders for the sale of bottles of the gel capsules.”

Kre-Alkalyn Creatine is a formula developed unlike regular Creatine, and thus is more easily absorbed into the muscle cells, as capsulated Kre-Alkalyn Creatine has been shown to more effective and economically efficient than creatine monohydrate powders. “All Soft Gels, Inc.’s liquid capsules are easily digestible and allows the consumer to safely consume Creatine to a fuller and more potent level,” explained Mr. Nelson.

You can visit the company website at www.allsoftgels.com.

Safe Harbor Disclaimer

This material includes forward-looking statements based on management's current reasonable business expectations. In this document, the words "can," "anticipates," "believes" and similar expressions identify certain forward-looking statements. These statements are made in reliance on the Private Securities Litigation Reform Act, Section 27A of the Securities Act of 1933, as amended. There are numerous risks and uncertainties that could result in actual results differing materially from expected outcomes. The material should be read in conjunction with the Company's current annual and quarterly reports filed with the SEC, which contain discussions of currently known factors that could significantly impact the Company's future.

Contact:
All Soft Gels, Inc.
Gene Nelson, CEO, (888) 916-5544
Contact
All Soft Gels Inc.
Gene Nelson
888-915-5544
www.allsoftgel.com
ContactContact
Categories